Mama-Match
Spry review
$199/mo semaglutide, $299/mo tirzepatide, three named co-founders (Gabriel Mullins, Sara Yoder, Tyler Bowman), no contracts, and a nurse practitioner reviewing intake within roughly 24 hours by Spry's own claim — undercut by an on-site 'FDA Approved' badge that overstates what's actually true about compounded GLP-1s, plus no pharmacy named and no state list disclosed. Its pricing only surfaces from the site's own compiled JavaScript rather than the visible marketing page, which is how it was confirmed for this review.
- HSA / FSA eligible
- Independently scored
- No insurance needed
Our medical guides link to published research and official medication information. Provider reviews compare published costs and terms. These source checks do not replace clinical review or advice from your healthcare professional.
Other providers to compare with Spry
Providers to compare, with referral partners listed first. Placement and score are separate; some links earn MamaGLP a commission.
- Meet CoreAge Rx
Compounded semaglutide and tirzepatide with advertised flat prices; clarify the offer and renewal rules before paying.
- Meet Gala Health
$179/mo for either medication, flat across doses, with a genuinely gentle microdose tier — if you can live with an annual plan and a pharmacy it will not name.
- Meet Oak
Oak advertises treatment from $119 and compounded and branded options; confirm the product, total and renewal before paying.
Spry at a glance
- Semaglutide
- $199/mo
- Tirzepatide
- $299/mo
- Coverage
- Not disclosed
- Brand-name
- Compounded only
How we scored Spry
Each factor is judged from Spry's actual pricing, disclosures and support, then combined into the Mama-Match Score of 55/100 using the same weighted six-factor framework we apply to every provider — never influenced by whether a provider pays us.
Considers the intake steps, payment timing and information available before enrollment.
Considers the full treatment cost, introductory offers and billing commitments.
Considers the described clinical team, appointment access and ways to contact a prescriber.
Considers published state coverage and treatment-specific eligibility limits.
Considers follow-up appointments, refill reviews and access to ongoing clinical support.
Considers cancellation deadlines, refund limits and prepaid commitments.
How we verified this review
- Last reviewed
- August 2026
- Confidence
- Medium
- Primary sources
Company website
$199 and $299, confirmed by reading the site's compiled code because the pages show nothing on their own. One claim deserves care: it displays an 'FDA Approved' badge over compounded medications, which are not FDA-approved finished products. No state list.
What to expect when you sign up
We walked Spry's public signup (August 2026) — a first-hand look at the process. We did not create accounts, enter medical information, or complete checkout, so this is what any visitor sees, not a patient's outcome.
- 1becomespry.com is a client-rendered app — pricing was confirmed by pulling and reading its actual JS bundle, not just the marketing page
- 2Three co-founders are named on-site: Gabriel Mullins, Sara Yoder, and Tyler Bowman
- 3No contracts required; a nurse practitioner reviews intake within roughly 24 hours per Spry's own claims
What we noticed
- Spry's homepage displays an 'FDA Approved' badge and 'FDA-approved treatments' copy — but compounded semaglutide and tirzepatide are not themselves FDA-approved finished drug products; worth reading that badge skeptically
- Three named co-founders is more personal accountability than most compounded-GLP-1 storefronts show
- No state-availability list found, and no pharmacy is named beyond generic language
Pricing
Prices re-verified
Compounded semaglutide
$199
Plan
Starting tier
Confirmed live by pulling Spry's own JS bundle (becomespry.com is a client-rendered app).
Compounded tirzepatide
$299
Plan
Starting tier
Confirmed the same way. Spry also sells three longevity peptides (BPC-157, NAD+, sermorelin) at $249-$299/mo — not GLP-1s, so left out of these rows.
HSA/FSA is usually accepted for GLP-1 telehealth — check your plan. Prices reflect what Spry disclosed publicly at our last review and change often; confirm the current number on Spry's site.
What we like
- Three named co-founders — more personal accountability than most compounded-GLP-1 storefronts
- No contracts required, with a stated ~24-hour nurse practitioner review of intake
- Also offers three longevity peptides if that's of interest beyond weight loss
The caveats
- Displays an 'FDA Approved' badge over compounded medications that are not themselves FDA-approved finished products
- No pharmacy named, and no state-availability list found
- Site is a client-rendered app, which made its own pricing harder to verify than a normal marketing page
Spry for moms: our verdict
$199/mo semaglutide, $299/mo tirzepatide, three named co-founders (Gabriel Mullins, Sara Yoder, Tyler Bowman), no contracts, and a nurse practitioner reviewing intake within roughly 24 hours by Spry's own claim — undercut by an on-site 'FDA Approved' badge that overstates what's actually true about compounded GLP-1s, plus no pharmacy named and no state list disclosed. Its pricing only surfaces from the site's own compiled JavaScript rather than the visible marketing page, which is how it was confirmed for this review. It runs about $199/mo, flat across every dose.
We looked at Spry the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.
What Spry actually costs
- Compounded semaglutide — Starting tier: $199/mo
- Compounded tirzepatide — Starting tier: $299/mo
That's roughly in line with our list's median of ~$179/mo.
Spry prices flat across doses, so it doesn't climb as your dose does — which matters, because most women spend months titrating up.
That price covers the consult and the medication.
The medications Spry prescribes
Spry lists semaglutide and tirzepatide. Offering both gives a prescribing clinician options, but PCOS or a history of gestational diabetes alone does not establish which medication is right for you. Compounded GLP-1s are not FDA-approved finished products. Confirm the exact formulation and dispensing pharmacy; an approved brand’s trial results do not establish the quality or equivalence of a compounded product.
Where it operates. Spry publishes no state list, so confirm it serves yours before you pay anything.
Where Spry fits — and where it doesn't — for moms
A good fit if…
- you want to discuss both semaglutide and tirzepatide with your prescribing clinician.
Look elsewhere if…
- you specifically want an FDA-approved brand-name pen with its own pregnancy and breastfeeding label.
- you need to discuss the right timing around pregnancy and nursing with your treating clinician before choosing. If comparing prices with CoreAge Rx, request the offer and terms separately from that clinical decision.
Trust, safety and oversight
Before choosing Spry, confirm the dispensing pharmacy and the clinician responsible for your prescription. Public information alone does not establish the quality of care you will receive. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.
Pregnancy and breastfeeding need separate discussions with your clinician. GLP-1 weight-loss treatment is not recommended during pregnancy. During breastfeeding, the exact drug and formulation matter: Wegovy tablets are not recommended because of the SNAC absorption ingredient. Injectable semaglutide and tirzepatide labels call for weighing benefits, risks and the limits of infant-safety data; they do not establish that treatment is safe for every nursing parent. Compounded products do not inherit FDA approval from the branded drug. Discuss your own medication and timing before starting or changing treatment.
The bottom line
Spry is a reasonable option — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For moms comparing another compounded offer, CoreAge Rx describes prices and terms to confirm for the selected dose and plan.
The bottom line
Best for: Moms who like seeing named founders behind a brand and will read the 'FDA Approved' badge skeptically rather than at face value.
Keep comparing Spry
Head-to-heads and alternatives
Ranked boards
- Best GLP-1 for moms — a gentle first step
- Best GLP-1 for women — PCOS, cycles, perimenopause
- Best GLP-1 for first-timers (easiest to start)
- Most affordable GLP-1 with honest, clear pricing
- Best semaglutide for mothers — price and practicality
- Best semaglutide for women — compounded vs brand
- Best semaglutide for young moms — postpartum and budget
- Best tirzepatide for mothers — is it worth the extra
- Best tirzepatide for women — PCOS and insulin resistance
- Best GLP-1 with bilingual / Spanish-language support
Spry, answered
- How much does Spry cost?
- As of our last review, Spry's published pricing starts around $199/mo ($199/mo semaglutide, $299/mo tirzepatide). Confirm the current all-in price on Spry's site before you commit.
- Is Spry safe to use while breastfeeding?
- Pregnancy and breastfeeding need separate discussions with your clinician. GLP-1 weight-loss treatment is not recommended during pregnancy. During breastfeeding, the exact drug and formulation matter: Wegovy tablets are not recommended because of the SNAC absorption ingredient. Injectable semaglutide and tirzepatide labels call for weighing benefits, risks and the limits of infant-safety data; they do not establish that treatment is safe for every nursing parent. Compounded products do not inherit FDA approval from the branded drug. Discuss your own medication and timing before starting or changing treatment.
- Does Spry offer both semaglutide and tirzepatide?
- Yes — Spry offers both. The choice depends on the exact product, your medical history and your clinician’s assessment; PCOS or a history of gestational diabetes alone does not make one medication the preferred treatment.
- Where does Spry land in your ranking?
- Spry scores 55/100 on our Mama-Match Score (rank #176), which weights six things that matter to a first-timer. Compare the scorecards and our published methodology before choosing a program.
Prices, states and verification reflect what Spry disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the published methodology. This is background information, not medical advice. Pregnancy and breastfeeding guidance depends on the drug and formulation. Read the current Wegovy label and Zepbound label. See our medical disclaimer and how we're funded.